ORPHAZYME A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,010 DKK | -7.76% |
|
+2.20% | -24.06% |
| Mar. 27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 1,100.00 | 1,400.00 | 2,905.00 |
| Spread/Res. | -8.18% | -27.86% | -65.23% |
| Spread/Supp. | +2.20% | +49.23% | +44.29% |
| Support | 988.30 | 676.80 | 700.00 |
- Stock Market
- Equities
- ORPHA Stock
- Charts Orphazyme A/S
